Andrenette M Fleming, MD in Arlington, TN - Medicare Obstetrics/gynecology

Andrenette M Fleming, MD is a medicare enrolled "Obstetrics & Gynecology" physician in Arlington, Tennessee. She went to East Tennessee State University Quillen College Of Medicine and graduated in 1998 and has 26 years of diverse experience with area of expertise as Obstetrics/gynecology. Her current practice location is 9005 Highway 64, Suite 101, Arlington, Tennessee. You can reach out to her office (for appointments etc.) via phone at (901) 383-7446.

Andrenette M Fleming is licensed to practice in Tennessee (license number MD0000039552) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1396804266.

Contact Information

	Andrenette M Fleming, MD
	9005 Highway 64, Suite 101, Arlington, TN 38002-8391
	(901) 383-7446
	(901) 383-7447

Physician's Profile

Full Name	Andrenette M Fleming
Gender	Female
Speciality	Obstetrics/gynecology
Experience	26 Years
Location	9005 Highway 64, Arlington, Tennessee
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Andrenette M Fleming attended and graduated from East Tennessee State University Quillen College Of Medicine in 1998

NPI Data:

NPI Number: 1396804266
Provider Enumeration Date: 12/07/2006
Last Update Date: 06/07/2010

Medicare PECOS Information:

PECOS PAC ID: 8527018860
Enrollment ID: I20070521000024

Medical Identifiers

Medical identifiers for Andrenette M Fleming such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1396804266	NPI	-	NPPES
2033962	Other	TN	UNISON
39813	Other	TN	TLC
4143455	Other	TN	BCBS
5882244	Medicaid	MS
3833454	Medicaid	TN

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207V00000X	Obstetrics & Gynecology	MD0000039552 (Tennessee)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Andrenette M Fleming is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Andrenette M Fleming, MD 165 Ben Cv, Henderson, TN 38340-1278 Ph: (731) 989-4339	Andrenette M Fleming, MD 9005 Highway 64, Suite 101, Arlington, TN 38002-8391 Ph: (901) 383-7446

News Archive

Female doctors experiencing domestic abuse fear the consequences of reporting it

Female doctors who suffer domestic abuse can feel unable to get help due to perceptions that it "should not happen to a doctor" and a judgemental culture in medical settings, a new study suggests.

Poor sleep linked to negative mood in women with bipolar disorder

Poor sleep is associated with negative mood in women with bipolar disorder, according to researchers at Penn State College of Medicine and University of Michigan Medical School.

Brain chemical dopamine plays key role in representing or encoding movement

Princeton University researchers have found that dopamine - a brain chemical involved in learning, motivation and many other functions - also has a direct role in representing or encoding movement. The finding could help researchers better understand dopamine's role in movement-related disorders such as Parkinson's disease.

Beckman Coulter Life Sciences' Avanti centrifuges combine high performance and application versatility

Avanti JXN-26 centrifuges from Beckman Coulter offer lab an intuitive interface and advanced data management features.

Comprehensive development strategy yields two potential drugs that block cancer-promoting pathways

A comprehensive drug development strategy that starts with extensive screening of potential targeting agents and then narrows down to a small-molecule prototype has yielded two potential drugs that block cancer-promoting pathways in novel ways, a team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in two papers published back-to-back online at the Proceedings of the National Academies of Science.

Andrenette M Fleming, MD - Medicare Obstetrics/gynecology in Arlington, TN